Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (131-140 of 297) with videos related to

Pageof 30
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 7, 2009
Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortexAtsuko Ikenouchi-Sugita, Yumiko Toyohira, Reiji Yoshimura, et al.
International Journal of Molecular Sciences|January 8, 2025
Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical SymptomatologyEnkhmurun Chibaatar, Rintarou Fujii, Atsuko Ikenouchi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 4, 2006
Risperidone in the treatment of psychotic depressionMakiko Goto, Reiji Yoshimura, Shingo Kakihara, et al.
International Journal of Psychiatry in Clinical Practice|December 6, 2011
Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patientsHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2007
Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?Masae Mitoma, Reiji Yoshimura, Atsuko Sugita, et al.
Human Psychopharmacology|June 24, 2009
Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependenceWakako Umene-Nakano, Reiji Yoshimura, Atsuko Ikenouchi-Sugita, et al.
Therapeutic Advances in Psychopharmacology|July 25, 2014
Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorderReiji Yoshimura, Hikaru Hori, Wakako Umene-Nakano, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|May 23, 2014
Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive DisorderKiyokazu Atake, Reiji Yoshimura, Hikaru Hori, et al.
Frontiers in Human Neuroscience|January 20, 2022
Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major DepressionHirofumi Tesen, Keita Watanabe, Naomichi Okamoto, et al.
Journal of Affective Disorders|June 1, 2011
Type A behavior pattern and hyperthymic temperament: possible association with bipolar IV disorderYumei Wang, Takeshi Terao, Nobuhiko Hoaki, et al.
Pageof 30

Showing results (131-140 of 297) with videos related to

Sort By:
Pageof 30
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 7, 2009
Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortexAtsuko Ikenouchi-Sugita, Yumiko Toyohira, Reiji Yoshimura, et al.
International Journal of Molecular Sciences|January 8, 2025
Evaluating Apelin as a Potential Biomarker in Major Depressive Disorder: Its Correlation with Clinical SymptomatologyEnkhmurun Chibaatar, Rintarou Fujii, Atsuko Ikenouchi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 4, 2006
Risperidone in the treatment of psychotic depressionMakiko Goto, Reiji Yoshimura, Shingo Kakihara, et al.
International Journal of Psychiatry in Clinical Practice|December 6, 2011
Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patientsHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2007
Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?Masae Mitoma, Reiji Yoshimura, Atsuko Sugita, et al.
Human Psychopharmacology|June 24, 2009
Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependenceWakako Umene-Nakano, Reiji Yoshimura, Atsuko Ikenouchi-Sugita, et al.
Therapeutic Advances in Psychopharmacology|July 25, 2014
Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorderReiji Yoshimura, Hikaru Hori, Wakako Umene-Nakano, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|May 23, 2014
Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive DisorderKiyokazu Atake, Reiji Yoshimura, Hikaru Hori, et al.
Frontiers in Human Neuroscience|January 20, 2022
Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major DepressionHirofumi Tesen, Keita Watanabe, Naomichi Okamoto, et al.
Journal of Affective Disorders|June 1, 2011
Type A behavior pattern and hyperthymic temperament: possible association with bipolar IV disorderYumei Wang, Takeshi Terao, Nobuhiko Hoaki, et al.
Pageof 30